Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.

OBJECTIVE To assess information and decision making preferences of patients on active surveillance (AS), and the factors influencing their decision. METHODS A cross-sectional sample of 180 patients on AS for <10 years completed a survey exploring the role men assumed with their physician in treatment decision making (TDM), factors influencing their decision to go on AS, and information preferences. RESULTS Thirty-five percent of patients reported assuming an active role in TDM, 38% a collaborative role and 27% a passive role. Results suggest that patients<60 years prefer to play an active role in TDM whereas, men>70 years prefer to play a passive role. Available treatment options, eating a 'prostate friendly' diet, and non-traditional therapies were identified as the top three information preferences. Patients with higher levels of anxiety wanted access to more information compared to those with lower levels of anxiety. The urologists' recommendation was rated the most important factor influencing patients' decisions to go on AS. CONCLUSION The urologist's recommendation for treatment continues to have the most influence on the decision to go on AS. Our results suggest that age has an impact on the role patients wish to assume in TDM. PRACTICE IMPLICATIONS Assessments of patients' information and decision preferences, and levels of anxiety are suggested for all prostate cancer patients considering AS.

[1]  David Chia,et al.  Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.

[2]  M. Cooperberg,et al.  Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. , 2003, The Journal of urology.

[3]  M. Kattan,et al.  Recall and attitudes in patients with prostate cancer. , 1999, Urology.

[4]  T. Pickles,et al.  The Self-Management of Uncertainty Among Men Undertaking Active Surveillance for Low-Risk Prostate Cancer , 2009, Qualitative health research.

[5]  B. G. Blijenberg,et al.  Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.

[6]  Thomas Wheeler,et al.  An analysis of men with clinically localized prostate cancer who deferred definitive therapy. , 2004, The Journal of urology.

[7]  P. Abrahamsson.  Prostate cancer: to treat or not to treat? , 2009, The Johns Hopkins medical letter health after 50.

[8]  M. Gleave,et al.  Comparing a Generic and Individualized Information Decision Support Intervention for Men Newly Diagnosed With Localized Prostate Cancer , 2007, Cancer nursing.

[9]  L. Degner,et al.  Empowerment of men newly diagnosed with prostate cancer. , 1997, Cancer nursing.

[10]  Donald E Bailey,et al.  Active surveillance for early‐stage prostate cancer , 2008, Cancer.

[11]  T. Pickles,et al.  Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. , 2009, Oncology nursing forum.

[12]  J. Steiner,et al.  Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote , 2006, Cancer.

[13]  Neil Fleshner,et al.  Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. , 2002, The Journal of urology.

[14]  M. Wallace.  Uncertainty and quality of life of older men who undergo watchful waiting for prostate cancer. , 2003, Oncology nursing forum.

[15]  P. Carroll,et al.  What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. , 2007, The Journal of urology.

[16]  J. Adolfsson.  Watchful waiting and active surveillance: the current position , 2008, BJU international.

[17]  S Larry Goldenberg,et al.  Assessing Information and Decision Preferences of Men With Prostate Cancer and Their Partners , 2002, Cancer nursing.

[18]  J. Concato,et al.  Treatment Decisions for Localized Prostate Cancer Asking Men What ’ s Important , 2000 .

[19]  E. Steyerberg,et al.  Do anxiety and distress increase during active surveillance for low risk prostate cancer? , 2010, The Journal of urology.

[20]  Hans Garmo,et al.  Radical prostatectomy versus watchful waiting in early prostate cancer. , 2005, The New England journal of medicine.

[21]  C. Parker,et al.  Active Surveillance With Selective Radical Treatment for Localized Prostate Cancer , 2007, Cancer journal.

[22]  C. Iselin,et al.  Treatment options, selection, and satisfaction among african american and white men with prostate carcinoma in north carolina , 1998, Cancer.

[23]  Dan Theodorescu,et al.  Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey. , 2003, Urology.

[24]  M. Emberton,et al.  Lifestyle and behavioural interventions for men on watchful waiting with uncomplicated lower urinary tract symptoms: a national multidisciplinary survey , 2003, BJU international.

[25]  S. Goldenberg,et al.  Patient acceptance of active surveillance as a treatment option for low‐risk prostate cancer , 2011, BJU international.

[26]  M. Gleave,et al.  Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer. , 2003, Oncology nursing forum.

[27]  Eric Horwitz,et al.  Decision-making strategies for patients with localized prostate cancer. , 2002, Seminars in urologic oncology.